The polylaminin and the path of science - The Subject #1680
A patient with spinal injury who regained the ability to walk has sparked hope and legal actions for early access to a drug called polylaminin, currently in research phases.
Daily Summary #1894: New Supreme Leader of Iran was injured in an attack that killed his father, says agency; Husband of police officer found dead with a gunshot wound in SP is under investigation; Next steps in the polylaminin research
The article discusses several significant updates including the injury of the new Supreme Leader of Iran during a conflict, the investigation of the husband of a murdered police officer in Brazil, and developments in polylaminin research.
Polylaminin: why the study was not published by scientific journals and what the next steps of the research are
The study on polylaminin has faced publication rejection from scientific journals due to discrepancies in patient recovery rates and the lack of prior registration in an international research database.
Tatiana Sampaio, researcher of polylaminin, participates in 'Science For Them' at USP in São Carlos
Researcher Tatiana Sampaio will speak at the 'Science For Them' event at the University of São Paulo in São Carlos, focusing on her work with polylaminin for spinal injury treatment.
The first to receive polylaminin in MG, woman says the medication is 'a sign of hope'
A woman from Governador Valadares, Brazil, became the first in Minas Gerais to receive an experimental treatment aimed at regenerating nerve connections after a spinal cord injury.
'Rehabilitation is decisive and cannot be sidelined in studies with polylaminin,' says doctor
A Brazilian doctor emphasizes the importance of prioritizing rehabilitation in the clinical studies of polylaminin, a substance being tested for acute spinal cord injury treatment.
Article about polylaminin has errors and will be revised, says researcher to newspaper
Biologist Tatiana Coelho de Sampaio announces that errors in a pre-print article on polylaminin as a treatment for spinal cord injury will be corrected before resubmission to scientific journals.
VIDEOS: NE1 of Saturday, March 7, 2026
A scientist admits errors in her graph and article writing, yet maintains the effectiveness of polylaminin.
VIDEOS: Jornal Anhanguera 1st Edition on Saturday, March 7, 2026
In an interview with G1, scientist Tatiana Sampaio acknowledged errors in a chart and article writing but maintains the effectiveness of polylaminin, while various political and social issues unfold in Brazil and internationally.
Patient who lost movement receives treatment with polylaminin in Salvador: 'Rekindled my faith'
A 38-year-old logistics operator in Salvador receives an experimental treatment for spinal cord injury using polylaminin at a private hospital, marking a significant step in medical research in Brazil.
Exclusive: polylaminin researcher admits mistakes in graph, writing problems, and claims research will have a new version
Researcher Tatiana Sampaio admitted errors in her study on polylaminin, which is suggested as a treatment for spinal cord injuries, and plans to release a revised version of the article.
Ethics Committee of HC-USP denies experimental use of polylaminin on sergeant who was shot and injured spinal cord
The Medical Ethics Committee at the Hospital das Clínicas, USP, denied the request for experimental treatment with polylaminin for a police sergeant who suffered a severe spinal cord injury.
Tatiana Sampaio, researcher of polylaminin, will be honored by Alerj
Tatiana Sampaio, a researcher from UFRJ, will receive the Benemérita title from the State of Rio de Janeiro for her work on polylaminin, an experimental substance for spinal cord injury treatment.
The dilemmas of polylaminin and healing
The article discusses the complexities surrounding polylaminin, a compound derived from placental protein, and the implications of claiming healing for those with spinal injuries.
'I want to be like before,' says the 1st young person from MT to receive polylaminin in experimental study
'I want to be like before,' says a 21-year-old from Rondonópolis, Brazil who is the first in his state to participate in an experimental treatment for spinal cord injuries using polylaminin.
Race for polylaminin outside clinical studies raises alarm about application risks
There has been a surge of over 5,000 people seeking polylaminin from Cristália and the courts, raising concerns among neurosurgeons about the substance's safety due to unverified efficacy.
Journalism and polylaminin
The Brazilian Academy of Neurology has urged caution regarding polylaminin due to a lack of evidence for its effectiveness, amidst a polarized public discourse fueled by media coverage.
Polylaminin is not yet a drug: specialists warn against 'hype' on social media
Experts caution that the biotechnological compound polylaminin, popularized for its potential in treating spinal cord injuries, is still unproven and should not be considered a cure.
Debate on polylaminin could clarify the boundaries of science
The discussion surrounding the Brazilian clinical research on polylaminin highlights both the potential benefits and limitations of the molecule, which may offer hope in treating severe spinal injuries.
Use of polylaminin is monitored in real time by society: 'Like a Big Brother', says researcher
Research on polylaminin, a substance being studied as a possible treatment for spinal cord injuries, is closely monitored by society, according to lead researcher Tatiana Sampaio.
Research on new medications, such as polylaminin, must follow strict international rules
The development of new medications, including polylaminin, requires adherence to strict international guidelines, particularly in clinical trials that involve control groups to assess efficacy and safety.
Polylaminin is promising, but must overcome clinical trials
Polylaminin shows promise as a potential treatment for severe spinal injuries but faces significant challenges in clinical testing.
How long will it take for us to know the effectiveness of polylaminin? Understand the substance in 16 topics
Polylaminin has generated significant attention on social media due to its association with reports of patient recovery, but experts urge caution due to a lack of robust clinical evidence supporting its efficacy and safety.
Delegate who survived accident with police vehicle receives dose of polylaminin in an attempt to walk again
Delegate Leonardo Sanches, paralyzed after a car accident, has received polylaminin treatment, becoming the first individual in Goiás to access this potentially life-altering therapy.
Polylaminin: How the studies were conducted, what are the results so far, and what does Anvisa say? Understand
A groundbreaking Brazilian study on polylaminin shows promising results in restoring movement after severe injuries, with a pivotal clinical study approved by Anvisa set to begin next month.
'Something told me to move my foot': a patient with spinal injury describes how he regained movement after the application of polylaminin
A recent study on polylaminin shows promise in reconnecting spinal cords, as illustrated by the case of a patient who regained movement after treatment.
Don't treat polylaminin as if it were the national team
The article discusses the recent hype surrounding polylaminin, a substance believed to regenerate spinal cord injuries, and its political implications in Brazil.
It’s #FAKE profile on Instagram that pretends to be Tatiana Sampaio, researcher of polylaminin
A fake Instagram profile impersonating Tatiana Sampaio, a researcher from UFRJ, has been identified, misleading followers with false information about her work.
Polylaminin researcher will receive a medal from the government of Espírito Santo
Tatiana Sampaio, a researcher from UFRJ, will be awarded the Jerônimo Monteiro medal by the Espírito Santo government for her work on polylaminin, a molecular treatment for spinal cord injuries.
Polylaminin: Maranhão native who received the substance begins home treatment and shows improvement
Hector Lucena, a 26-year-old agronomy student from Balsas, Maranhão, has begun at-home treatment with polylaminin for spinal cord trauma and reports improvements in his health.
Patient from Sergipe receives treatment with polylaminin
A 27-year-old woman from Sergipe has received a groundbreaking treatment involving polylaminin, which may restore movement to individuals with paraplegia or quadriplegia.
Polylaminin: Tetraplegic athlete from Paraná applies compound that 'trended' with positive motor recovery results
A tetraplegic athlete in Brazil has seen positive results from an experimental treatment using polylaminin, a compound derived from a protein produced in the human body.
VIDEO: Reporter Flávia Cintra hugs biologist Tatiana Sampaio, researcher leading studies on polylaminin
Reporter Flávia Cintra shares an emotional moment with biologist Tatiana Sampaio during a segment on the substance polylaminin, which offers hope for those with spinal cord injuries, going viral on social media.
VIDEOS: Good Morning Minas, Monday, February 23, 2026
The article covers various topics such as severe weather in Brazil, a substance called polylaminin that reconnects the spinal cord, state football matches, legal cases involving exploitation of minors, and political tensions related to Bolsonaro.
Polylaminin: the substance that 'reconnects' the spinal cord and brings hope to people with paraplegia
Polylaminin is a new substance being researched in Brazil that shows promise for reconnecting the spinal cord and providing hope for individuals suffering from paraplegia.
This is Fantastic: the advances in experimental treatments with polylaminin
The article discusses promising advancements in experimental treatments involving polylaminin, a placenta-derived protein that may restore movement in patients with severe spinal cord injuries.
VIDEO: João Gomes interrupts show in Sapucaí to honor scientist leading research on polylaminin
Singer João Gomes interrupted a performance to pay tribute to researcher Tatiana Sampaio, who is recognized for her work on polylaminin for treating acute spinal cord injuries.
Polylaminin: student from Balsas is the second patient in MA to receive the substance
Hector Lucena, a 26-year-old agriculture student from Balsas, became the second person in Maranhão to receive polylaminin during an experimental procedure on November 21.
Scientific societies call for caution and precision in the debate over poly-laminin
Scientific societies in Brazil urge caution in the discussion surrounding poly-laminin, a protein under investigation for spinal cord injury regeneration, emphasizing the importance of distinguishing experimental research from established clinical application.
Polylaminin and Tatiana Sampaio go viral on social media, but fall well below Virginia, says survey
Biologist Tatiana Sampaio has gained 16 million interactions on social media, receiving significant attention for her research on polylaminin, a protein aimed at aiding spinal cord injury regeneration.
Tatiana Sampaio at IFTM in Patrocínio: how to participate in the event with the scientist who developed a molecule that can reverse spinal injuries
Tatiana Sampaio will be speaking at the IFTM in Patrocínio on March 12, focusing on her research that could aid recovery from spinal injuries.
Daily recap #1868: Argentina's Chamber approves labor reform, which returns to the Senate; US Supreme Court decides on legality of Trump's tariff; The steps of experimental treatment with polylaminin
Argentina's Chamber of Deputies has approved a labor reform which now goes back to the Senate, while the US Supreme Court is set to rule on Trump's tariff legality, and a patient has regained ability to walk thanks to a new treatment with polylaminin.
Patient walks again and polylaminin trends; understand what the substance can do and what is still unknown
Polylaminin has recently gained attention on social media due to a patient's recovery and ongoing discussions about its potential and patent issues in Brazil.
First maranhense to receive polylaminin, shot PM shows improvement
Military police officer Romildo Leobino is showing signs of improvement after undergoing an experimental treatment with polylaminin following his injury during an operation.
Polylaminin: student shot inside school in PI cannot participate in innovative treatment
João Lucas Campelo, a 17-year-old student who became quadriplegic after being shot, is unable to undergo an experimental polylaminin treatment due to his health condition and other constraints.
Three patients who received polylaminin by court order die in RJ, PR, and ES
Three patients who received polylaminin as part of a court order have died in Brazil, with deaths attributed to pre-existing medical issues, according to the producing laboratory.
Youngest patient in the country to receive polylaminin reports movement in his hands: 'I couldn't move before'
Luiz Otávio Santos Nunez, the youngest patient in Brazil to receive polylaminin, reports regaining some movement in his fingers following the experimental treatment after a serious injury.
Polylaminin: a molecule discovered in Brazil 'by chance' that became hope to reverse spinal cord injuries
Polylaminin, a modified version of the naturally occurring laminin protein, is being studied as a new potential treatment for spinal cord injury victims in Brazil, although it is still in early clinical trial phases.
Podcast: the Brazilian experimental drug that may be hope for spinal cord injuries
The podcast discusses polylaminin, an experimental drug showing promise in restoring movement for patients with spinal cord injuries, highlighted by the case of a Brazilian influencer who regained arm movement after treatment.